Ignite Creation Date:
2024-07-17 @ 10:49 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06463379
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-06-01
Brief Title:
The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis
Sponsor:
Sohag University
Organization:
Sohag University
Study Overview
Official Title:
The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Interventional phase 3 study aiming to unravel the value of pulse steroids in achieving remission or low disease activity in refractory active JIA
Detailed Description:
First group will receive 2 consecutive days intravenous pulse of 125 mg methylprednisolone
Second group will not receive additional drugs Assessment was done at baseline and every month for 3 months for both groups using Juvenile Arthritis Disease Activity Score JADAS and the American College of Rheumatology Pediatric 30 50 and 70 response criteria ACR Pedi 30 50 70
Second group will not receive additional drugs Assessment was done at baseline and every month for 3 months for both groups using Juvenile Arthritis Disease Activity Score JADAS and the American College of Rheumatology Pediatric 30 50 and 70 response criteria ACR Pedi 30 50 70
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None